2BB score and signals
Estrella Immunopharma, Inc.’s current 2BB score is 23 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 7 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 25 | Weak |
| Quality | 20 | Weak |
| Risk | 83 | Very High |
Estrella Immunopharma, Inc. (ESLA) Stock Score & Signals
Estrella Immunopharma, Inc. (ESLA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 23 out of 100.
Company facts
| Headquarters | Emeryville, California, United States |
| Founded | 2006 |
| 52-week range | $0.30 – $3.15 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-16 | — | -0.0714 | — | $0.00 |
| 2026-11-10 | — | -0.0816 | — | $0.00 |
| 2026-03-18 | -0.35 | -0.1836 | — | — |